These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 34922945)
21. Differential Cell Susceptibilities to Kras Shi C; Pan FC; Kim JN; Washington MK; Padmanabhan C; Meyer CT; Kopp JL; Sander M; Gannon M; Beauchamp RD; Wright CV; Means AL Cell Mol Gastroenterol Hepatol; 2019; 8(4):579-594. PubMed ID: 31310834 [TBL] [Abstract][Full Text] [Related]
22. Numb regulates acinar cell dedifferentiation and survival during pancreatic damage and acinar-to-ductal metaplasia. Greer RL; Staley BK; Liou A; Hebrok M Gastroenterology; 2013 Nov; 145(5):1088-1097.e8. PubMed ID: 23891977 [TBL] [Abstract][Full Text] [Related]
23. Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer. Azizi N; Toma J; Martin M; Khalid MF; Mousavi F; Win PW; Borrello MT; Steele N; Shi J; di Magliano MP; Pin CL Oncogene; 2021 Apr; 40(17):3118-3135. PubMed ID: 33864001 [TBL] [Abstract][Full Text] [Related]
24. Early requirement of Rac1 in a mouse model of pancreatic cancer. Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285 [TBL] [Abstract][Full Text] [Related]
25. Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. Hidalgo-Sastre A; Brodylo RL; Lubeseder-Martellato C; Sipos B; Steiger K; Lee M; von Figura G; Grünwald B; Zhong S; Trajkovic-Arsic M; Neff F; Schmid RM; Siveke JT Am J Pathol; 2016 Nov; 186(11):2934-2944. PubMed ID: 27639167 [TBL] [Abstract][Full Text] [Related]
26. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16. Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115 [TBL] [Abstract][Full Text] [Related]
27. The E3 ubiquitin ligase TRIP12 is required for pancreatic acinar cell plasticity and pancreatic carcinogenesis. Brunet M; Vargas C; Fanjul M; Varry D; Hanoun N; Larrieu D; Pieruccioni L; Labrousse G; Lulka H; Capilla F; Ricard A; Selves J; Couvelard A; Gigoux V; Cordelier P; Guillermet-Guibert J; Dufresne M; Torrisani J J Pathol; 2024 Aug; 263(4-5):466-481. PubMed ID: 38924548 [TBL] [Abstract][Full Text] [Related]
28. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas. Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042 [TBL] [Abstract][Full Text] [Related]
29. The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice. Martinelli P; Madriles F; Cañamero M; Pau EC; Pozo ND; Guerra C; Real FX Gut; 2016 Mar; 65(3):476-86. PubMed ID: 25596178 [TBL] [Abstract][Full Text] [Related]
30. AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53. Zhang Z; Li H; Deng Y; Schuck K; Raulefs S; Maeritz N; Yu Y; Hechler T; Pahl A; Fernández-Sáiz V; Wan Y; Wang G; Engleitner T; Öllinger R; Rad R; Reichert M; Diakopoulos KN; Weber V; Li J; Shen S; Zou X; Kleeff J; Mihaljevic A; Michalski CW; Algül H; Friess H; Kong B Gastroenterology; 2021 Nov; 161(5):1601-1614.e23. PubMed ID: 34303658 [TBL] [Abstract][Full Text] [Related]
31. RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation. Pan L; Mulaw MA; Gout J; Guo M; Zarrin H; Schwarz P; Baumann B; Seufferlein T; Wagner M; Oswald F Cell Mol Gastroenterol Hepatol; 2023; 16(5):783-807. PubMed ID: 37543088 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer. Wong CH; Li YJ; Chen YC World J Gastroenterol; 2016 Aug; 22(31):7046-57. PubMed ID: 27610015 [TBL] [Abstract][Full Text] [Related]
33. Oncogenic KRas-induced Increase in Fluid-phase Endocytosis is Dependent on N-WASP and is Required for the Formation of Pancreatic Preneoplastic Lesions. Lubeseder-Martellato C; Alexandrow K; Hidalgo-Sastre A; Heid I; Boos SL; Briel T; Schmid RM; Siveke JT EBioMedicine; 2017 Feb; 15():90-99. PubMed ID: 28057438 [TBL] [Abstract][Full Text] [Related]
34. Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice. Perusina Lanfranca M; Zhang Y; Girgis A; Kasselman S; Lazarus J; Kryczek I; Delrosario L; Rhim A; Koneva L; Sartor M; Sun L; Halbrook C; Nathan H; Shi J; Crawford HC; Pasca di Magliano M; Zou W; Frankel TL Gastroenterology; 2020 Apr; 158(5):1417-1432.e11. PubMed ID: 31843590 [TBL] [Abstract][Full Text] [Related]
35. The suppressive efficacy of THZ1 depends on KRAS mutation subtype and is associated with super-enhancer activity and the PI3K/AKT/mTOR signalling in pancreatic ductal adenocarcinoma: A hypothesis-generating study. Huang L; Yang H; Chen K; Yuan J; Li J; Dai G; Gu M; Shi Y Clin Transl Med; 2023 Dec; 13(12):e1500. PubMed ID: 38037549 [TBL] [Abstract][Full Text] [Related]